U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06954610) titled 'Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation' on April 16.
Brief Summary: Background
Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting up to 10% of the elderly. Ischemic stroke is the main complication of AF and cardioembolism is one of the leading causes of ischemic stroke, accounting for approximately one third of cases. Oral anticoagulant therapy (OAC) is a cornerstone in stroke prevention in patients with AF. According to randomized controlled trials of direct oral anticoagulants, a residual risk of ischemic stroke of 1-2% per year for so-called "breakthrough stroke" remai...